Inhibitor Therapeutics, Inc. Interest Expense, Related Party
Inhibitor Therapeutics, Inc. (INTI) reported Interest Expense, Related Party of $7.71 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseRelatedParty · last filed 2022-11-14
- Inhibitor Therapeutics, Inc. interest expense, related party for the quarter ending 2022-09-30 was $7.71K, a 60.42% increase year-over-year.
- Inhibitor Therapeutics, Inc. interest expense, related party for the quarter ending 2022-06-30 was $6.76K, a 90.67% increase year-over-year.
- Inhibitor Therapeutics, Inc. interest expense, related party for the quarter ending 2022-03-31 was $5.41K, a 221.07% increase year-over-year.
- Inhibitor Therapeutics, Inc. interest expense, related party for the quarter ending 2021-09-30 was $4.80K.
| Period end | Interest Expense, Related Party 3 month | Interest Expense, Related Party 6 month | Interest Expense, Related Party 9 month |
|---|---|---|---|
| 2022-09-30 | $7.71K 10-Q · filed 2022-11-14 | $14.47K derived: sum of 2 quarters · filed 2022-11-14 | $19.88K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $6.76K 10-Q · filed 2022-08-12 | $12.17K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $5.41K 10-Q · filed 2022-05-13 | ||
| 2021-09-30 | $4.80K 10-Q · filed 2022-11-14 | $8.35K derived: sum of 2 quarters · filed 2022-11-14 | $10.04K 10-Q · filed 2022-11-14 |
| 2021-06-30 | $3.55K 10-Q · filed 2022-08-12 | $5.23K 10-Q · filed 2022-08-12 | |
| 2021-03-31 | $1.69K 10-Q · filed 2022-05-13 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-13 | $0.00 10-Q · filed 2021-08-13 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-14 |